Zeneca Group plc (NYSE ticker ZEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zeneca Group plc (NYSE ticker ZEN)

ZEN 77.48

0.0%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (61)	12/8/1998 6:11:00 PM
From: Steven Messina,L.M.T.	Read Replies (1) of 75

From the Fool: Dec 08, 1998 (6:02 PM ET) - The Motley Fool Evening News Swedish drug maker Astra AB (NYSE:A - news) jumped $3 5/8 to $21 7/8 and British counterpart Zeneca Group PLC (NYSE:ZEN - news) rose $4 1/4 to $45 before trading in both stocks was halted at around 1:30 p.m. Eastern time. Shortly thereafter, the companies announced that they are in "advanced" discussions that could lead to a possible merger. If a deal can be worked out, the combined company will sport Zeneca's stable of cancer treatments, led by Zestril, and Astra's well-established Losic ulcer franchise, which is marketed as Prilosic in the U.S. and accounted for about 55% of Astra's Q3 sales. Rumors that Astra was seeking a merger with Zeneca, Germany's Bayer AG, or even U.S. drug heavyweight Schering-Plough (NYSE:SGP - news) have been in the markets almost all year. With 1999 fast approaching, those rumors appear to be on the cusp of becoming reality.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next